Diagnostic challenge and surgical decision making for a duodenal spindle cell tumor mimicking a gastrointestinal stromal tumor

Imagine the human body as a bustling city, and the duodenum (the first stretch of the small intestine) as a busy, winding subway tunnel right next to a massive, sensitive power station called the pancreas. In this story, a 55-year-old woman arrived at the hospital with a grumbling stomach, nausea, and vomiting, as if her internal subway was stuck in a traffic jam.

When the doctors took a high-tech "satellite photo" of her insides using a contrast-enhanced CT scan, they spotted a suspicious, lumpy intruder. It was a soft-tissue mass, about 6.0 × 3.8 cm in size, hiding right behind the pancreatic head and hugging the duodenum tight. Based on how it looked, the doctors' best guess was that it was a Gastrointestinal Stromal Tumor (GIST), a common type of growth in that area. It was like seeing a shadowy figure in a fog and assuming it's a familiar neighbor.

To get a closer look, the doctors tried the standard detective move: a gastroscopic biopsy. They slid a tiny camera and a microscopic grabber down the throat to pinch a piece of the tissue. But here's the twist: the grabber only snatched some surface-level debris—heterotopic fundic glands and signs of chronic inflammation. It was like trying to identify a deep-sea monster by only scooping up a few bubbles from the surface; the sample didn't match the giant shadow seen on the satellite photo. The biopsy was a dead end, failing to explain the 6.0 × 3.8 cm mystery.

Because the patient was still feeling sick and the doctors couldn't be sure what the deep-seated lump really was, they decided to go in and take a look for real. They planned a laparoscopic (keyhole) surgery to remove the tumor. But once they opened the door, the reality was much stickier than expected. The tumor wasn't just sitting there; it was firm and densely glued to a major highway in the body: the inferior vena cava (a huge vein). Trying to peel it off with tiny tools would have been like trying to untangle a knot from a live electrical wire without cutting the power. The risk of a major accident was too high.

So, the surgical team switched gears. They converted to an open surgery and performed a pancreaticoduodenectomy. Think of this as a major construction project where, instead of just removing one faulty pipe, they had to carefully dismantle and rebuild the entire junction where the pancreas, duodenum, and bile ducts meet. They also removed the gallbladder. The operation took from 08:40 to 14:20, and the patient received 1.5 U of red blood cells and 200 mL of plasma to help her through the day.

When the removed tissue was finally examined under a microscope, the real identity of the intruder was revealed. It was a spindle cell tumor of mesenchymal origin. But was it the suspected GIST? The lab tests said "no way." The tumor cells were negative for DOG-1 and CD117 (the usual ID badges for GISTs) but positive for SMA (a marker for muscle-like cells). This suggested the tumor was actually leaning toward myogenic differentiation—meaning it was more like a muscle-related growth than the originally suspected GIST. The paper suggests this cautious label is the most appropriate description given the evidence.

The surgery was a success. The patient's recovery had a few bumps, like a temporary fever and some drainage issues, but these were smoothed out with medicine and care. By November 23, 2023, she was sent home feeling good.

The story doesn't end there. The patient has been checked up on regularly. As of May 28, 2025, she has undergone four abdominal CT scans and one MRI. The results? No signs of the tumor coming back or spreading anywhere else. The paper suggests this points to a favorable short- to mid-term outcome.

The big lesson from this case isn't just about the tumor itself, but about how doctors make tough calls. Sometimes, the "what" (the exact diagnosis) is a mystery until after the surgery. In this case, the decision to perform such a major operation wasn't driven by a confirmed preoperative diagnosis, but by the "where" and "how"—specifically, whether the tumor could be safely removed without causing disaster. When a deep, stubborn mass is glued to vital structures, the paper suggests that the strategy should be guided by the ability to safely cut it out, rather than waiting for a perfect label that might never come before the knife is out. The patient and her family understood this uncertainty and agreed that removing the mystery was the safest path forward.